|
Real-time Estimate
Cboe BZX
20:15:49 28/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 46.78 USD | +0.24% |
|
-7.21% | -50.98% |
| 08-27 | Health Care Down on Rotation Out of Biotech -- Health Care Roundup | DJ |
| 08-27 | Boston Scientific Shares Fall After Catheter Recall | MT |
| Market Cap | 67.64B 58.06B 54.36B 49.77B 93.76B 6,460B 94.03B 644B 252B 3,256B 254B 248B 10,775B | P/E 2026 * |
17.4x | P/E 2027 * | 18.4x |
|---|---|---|---|---|---|
| Enterprise Value | 76.35B 65.54B 61.36B 56.19B 106B 7,292B 106B 727B 284B 3,675B 287B 280B 12,164B | EV / Sales 2026 * |
3.57x | EV / Sales 2027 * | 3.27x |
| Free-Float |
82.47% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Boston Scientific Corporation
| 1 day | +0.22% | ||
| 1 week | -7.21% | ||
| Current month | +0.02% | ||
| 1 month | +1.48% | ||
| 3 months | -4.83% | ||
| 6 months | -38.68% | ||
| Current year | -50.98% |
| 1 week | 46.6 |  | 50.38 |
| 1 month | 42.55 | | 52.99 |
| Current year | 42.2 | | 100.9 |
| 1 year | 42.2 | | 109.5 |
| 3 years | 42.2 | | 109.5 |
| 5 years | 34.98 | | 109.5 |
| 10 years | 19.67 | | 109.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CEO | Chief Executive Officer | 61 | 01/11/2011 |
Jonathan Monson
DFI | Director of Finance/CFO | 52 | 30/06/2025 |
Kenneth Stein
CTO | Chief Tech/Sci/R&D Officer | - | 01/09/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CHM | Chairman | 61 | 03/05/2016 |
Edward Ludwig
BRD | Director/Board Member | 74 | 01/03/2014 |
Ellen Zane
BRD | Director/Board Member | 74 | 15/04/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25/08/26 | Buy | Director | 2,040 | 0.0001% | ||
| 11/08/26 | Other | Controller/Auditor | 2,930 | 0.0002% | ||
| 10/08/26 | Other | Chief Financial Officer | 9,908 | 0.0007% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.21% | -7.21% | -55.80% | -13.11% | 67.64B | |
| -1.78% | -1.44% | +26.64% | +13.76% | 233B | |
| +0.03% | -1.45% | +5.06% | -17.52% | 152B | |
| +1.17% | -2.03% | -21.67% | +23.11% | 130B | |
| +0.28% | +0.42% | +11.01% | +18.60% | 51.85B | |
| +0.66% | -1.69% | -16.57% | -13.62% | 50.91B | |
| -2.52% | -3.39% | +22.93% | +28.09% | 44.46B | |
| -1.74% | +0.70% | +38.95% | +46.95% | 41.39B | |
| +1.35% | +3.38% | -13.08% | +47.86% | 34.01B | |
| -3.66% | -0.34% | +120.49% | +38.22% | 34.38B | |
| Average | -0.58% | +0.28% | +11.80% | +17.23% | 83.91B | |
| Weighted average by Cap. | -0.53% | -0.26% | +7.69% | +10.80% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 21.37B 18.34B 17.17B 15.72B 29.62B 2,041B 29.7B 203B 79.48B 1,028B 80.22B 78.48B 3,404B | 22.33B 19.17B 17.95B 16.43B 30.96B 2,133B 31.04B 212B 83.07B 1,075B 83.84B 82.03B 3,557B |
| Net income | 3.84B 3.3B 3.09B 2.83B 5.32B 367B 5.34B 36.53B 14.28B 185B 14.41B 14.1B 612B | 3.69B 3.16B 2.96B 2.71B 5.11B 352B 5.12B 35.08B 13.71B 177B 13.84B 13.54B 587B |
| Net Debt | 8.72B 7.48B 7.01B 6.41B 12.08B 833B 12.12B 82.96B 32.43B 420B 32.73B 32.02B 1,389B | 5.45B 4.68B 4.38B 4.01B 7.56B 521B 7.58B 51.88B 20.28B 262B 20.47B 20.03B 869B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/08/26 | $46.76 | +0.19% | 5,464,715 |
| 27/08/26 | $46.67 | -3.11% | 16,277,169 |
| 26/08/26 | $48.17 | -3.39% | 36,584,800 |
| 25/08/26 | $49.86 | +1.73% | 17,368,920 |
| 24/08/26 | $49.01 | -2.70% | 22,027,880 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BSX Stock
Select your edition
All financial news and data tailored to specific country editions
